| 期刊論文| 1. | Van Raalte, D.、Ouwens, D.、Diamant, M.(2009)。Novel insights into glucocorticoid mediated diabetogenic effects: Towards expansion of therapeutic options?。European Journal of Clinical Investigation，39(2)，81-93。   | | 2. | Tamez-Pérez, H. E.、Quintanilla-Flores, D. L.、Rodríguez-Gutiérrez, R.(2015)。Steroid hyperglycemia: prevalence, early detection and therapeutic recommendations: a narrative review。World J Diabetes，6，1073-1081。 | | 3. | Kim, S. Y.、Yoo, C. G.、Lee, C. T.(2011)。Incidence and risk factors of s teroid-induced diabetes in patients with respiratory disease。J Korean Med Sci，26，264-267。 | | 4. | Karthik, R. N.、Navin, P.、Sudha, V.(2016)。Clinical and biochemical profile of steroid-induced diabetes。Asian J Pharm Clin Res，9，262-266。 | | 5. | Katsuyama, T.、Sada, K. E.、Namba, S.(2015)。Risk factors for the development of glucocorticoid-induced diabetes mellitus。Diabetes Res Clin Pract，108，273-279。 | | 6. | Bansal, N.(2015)。Prediabetes diagnosis and treatment: a review。World J Diabetes，6，296-303。 | | 7. | Tabák, A. G.、Herder, C.、Rathmann, W.(2012)。Prediabetes: a high-risk state for developing diabetes。Lancet，379，2279-2290。 | | 8. | Koppe, L.、Pelletier, C. C.、Alix, P. M.(2014)。Insulin resistance in chronic kidney disease: new lessons from experimental models。Nephrol Dial Transplant，29，1666-1674。 | | 9. | Whitworth, J. A.、Stewart, P. M.、Burt, D.(1989)。The kidney is the major site of cortisone production in man。Clin Endocrinol，31，355-361。 | |